Clark McDonough, DO
Critical Care Medicine · Dalton, GANPI 1578531935
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $221 of the $328 with a category attached, or 67.2%. United Therapeutics Corporation accounts for 70.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $125 and has fallen 74.3% since, to $32 in 2024.
Across 9 payments — averaging $36.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$232
- Olympus America Inc.$29
- AbbVie$18
- ANI Pharmaceuticals, Inc.$18
- AstraZeneca$17
- Novo Nordisk$14
Across 15 payments — averaging $6438.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beigene, Ltd.$88K
- United Therapeutics Corporation$8K
What the payments were for
- Speaking & faculty fees$10030%
- Food & beverage$22167%
- Education$82%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 3 | $232 |
| Olympus America Inc. | 2 | $29 |
| AbbVie | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Novo Nordisk | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORENITRAM$125
How this compares
$328 in reported general payments places this provider in the 55th percentile of 265 critical care medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Dalton
- Salman FidahusseinLagrange$852K
- Bruce FriedmanAugusta$629K
- Gregory MauldinSnellville$221K
- Ramzy RimawiAtlanta$72K
- Rafael Alba YunenBrunswick$58K
- April McDonaldGainesville$41K
- Matthew SchmittAtlanta$32K
- Prasad GarimellaBraselton$20K
- James PalazzoloAlbany$16K
- Ramana RaoAlbany$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.